 The main objective of the study is to design and validate the blood based PDx gene expression assay for the early diagnosis of Parkinsons disease patients. Differential diagnosis includes patients with Multiple System Atrophy, Progressive Supranuclear Palsy, Corticobasal Degeneration, Lewy Body Dementia, Essential Tremor and Normal Controls. 